| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |